Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease: a Feasibility Trial

NCT02960503 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT02960503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02960503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease: a Feasibility Trial
Lead sponsor
Vanderbilt University
Phase
Phase 1/2
Overall status
Withdrawn
Start date
September 30, 2016
Completion date
October 31, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease